These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7763030)

  • 1. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
    Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC
    Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas.
    Jiang SX; Sato Y; Kuwao S; Kameya T
    J Pathol; 1995 Oct; 177(2):135-8. PubMed ID: 7490679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 in small cell lung carcinoma cells.
    Ikegaki N; Katsumata M; Minna J; Tsujimoto Y
    Cancer Res; 1994 Jan; 54(1):6-8. PubMed ID: 8261463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
    Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of non-small cell lung cancer. New diagnostic approaches.
    Linnoila I
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
    Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
    Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
    Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
    Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preliminary estimation of bcl-2, bcl-X(L) and p53 genes expression in locally advanced non-small cell lung cancer.
    Karczmarek-Borowska B; Filip A; Zdunek M; Korobowicz E; Wojcierowski J; Korszeń-Pilecka I; Furmanik F
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):124-31. PubMed ID: 15314971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
    Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
    Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
    Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Tumour Biol; 1996; 17(6):341-4. PubMed ID: 8938949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.